Summary of findings table ‐ Rifampin/rifampicin vs placebo
Risk for at least one adverse event per patient · participants with cholestatic pruritus (CP)
It is very uncertain whether summary of findings table ‐ Rifampin/rifampicin changes risk for at least one adverse event per patient compared with placebo (very low certainty).
1 finding from 1 review
- Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes onlyRR 0.29 [0.03, 2.51]1 study · 39 participantsVery low